Prescrire International: Corporate influence over clinical research
Related PPRC Members:
1 July 2012
Corporate influence over clinical research: considering the alternatives
Funding drug research independent of drug companies: a pipe dream or a public health necessity?
PPRC Member, Marc-André Gagnon, presents a case for independent funding of pharmacautical research in this Prescrire Outlook article published July 2012.
Marc-André Gagnon